Emergency Management of Hyperkalemia and AKI in Advanced CKD
This patient requires immediate ED evaluation with ECG monitoring and acute hyperkalemia treatment, but fluid administration should be approached cautiously given the advanced CKD (GFR 16) and acute-on-chronic kidney injury.
Immediate ED Workup
Critical First Steps
- ECG immediately - This is the most important initial test to assess for cardiac membrane instability from K+ 6.0 1
- Repeat potassium level - Rule out pseudohyperkalemia from hemolysis, fist clenching, or poor phlebotomy technique before aggressive treatment 1
- Assess volume status clinically - Look for signs of hypervolemia (edema, elevated JVP, pulmonary crackles) versus hypovolemia (orthostasis, dry mucous membranes, decreased skin turgor)
Essential Laboratory Workup
- Complete metabolic panel with bicarbonate level
- Complete blood count
- Urinalysis with microscopy
- Fractional excretion of sodium (FENa) to differentiate prerenal from intrinsic AKI 2
- Venous blood gas if metabolic acidosis suspected
- Review medication list for nephrotoxins, NSAIDs, RAASi 1
Imaging
- Renal ultrasound to rule out obstructive uropathy, particularly important given the acute decline in kidney function 2
Acute Hyperkalemia Management
Treatment Algorithm Based on ECG and K+ Level
If ECG shows changes (peaked T waves, widened QRS, PR prolongation):
- IV calcium gluconate 10 mL of 10% solution immediately - Stabilizes cardiac membrane within 1-3 minutes 1
For K+ 6.0 with or without ECG changes, initiate redistribution therapy:
- IV insulin 10 units + 50 mL dextrose - Shifts K+ intracellularly within 30-60 minutes 1
- Nebulized albuterol 20 mg in 4 mL - Additional intracellular shift, though effect lasts only 2-4 hours 1
- Monitor glucose closely to prevent hypoglycemia
Additional measures based on clinical context:
- Sodium bicarbonate IV - Only if metabolic acidosis is present 1
- Loop diuretics (furosemide) - Only if patient is hypervolemic AND non-oliguric with residual kidney function 1
- Consider hemodialysis - If patient is oliguric, has ESRD-level function, or hyperkalemia is refractory to medical management 1
Fluid Management Strategy
Critical Decision Point: To Give Fluids or Not?
DO NOT automatically give IV fluids in this scenario. The approach depends entirely on volume status assessment:
Give IV fluids IF:
- FENa <1% suggesting prerenal azotemia 2, 3
- Clinical signs of hypovolemia present
- Patient is taking diuretics that may have caused volume depletion
- Use isotonic saline cautiously in small boluses (250-500 mL), reassessing frequently
AVOID or minimize fluids IF:
- Patient shows signs of hypervolemia (common in GFR 16)
- FENa >2% suggesting intrinsic renal disease 2
- Patient is oliguric
- Risk of pulmonary edema given severely reduced GFR
Key pitfall: At GFR 16, this patient has minimal reserve for handling volume. Aggressive fluid resuscitation can precipitate pulmonary edema and worsen outcomes. The creatinine rise from 3.62 to 4.16 may represent acute-on-chronic kidney disease, but the modest change (0.54 mg/dL) in the context of advanced CKD may not indicate significant volume depletion 4.
Determining AKI Etiology
This patient meets KDIGO criteria for AKI Stage 1 (creatinine increase >0.3 mg/dL within presumed 48 hours or >1.5x baseline) 4. Classify as:
- Prerenal: FENa <1%, responds to cautious volume
- Intrinsic renal: FENa >2%, muddy brown casts on urinalysis, no response to volume
- Postrenal: Hydronephrosis on ultrasound 2
Disposition and Monitoring
Admit to monitored bed for:
- Continuous cardiac monitoring given K+ 6.0
- Serial potassium checks every 2-4 hours until <5.5 mmol/L
- Reassess creatinine and GFR trajectory
- Nephrology consultation for potential dialysis initiation 5
Consider urgent dialysis if:
- Hyperkalemia refractory to medical management
- Progressive oliguria develops
- Severe metabolic acidosis
- Volume overload with pulmonary edema 1
Medication Review
- Stop or hold RAASi (ACE inhibitors, ARBs, aldosterone antagonists) temporarily until hyperkalemia resolves 1
- Discontinue NSAIDs, potassium supplements, potassium-sparing diuretics
- Review for calcineurin inhibitors if transplant patient 6, 7
- Plan to reassess K+ within 1 week after any medication changes 1
Important note: Recent evidence shows both hemodialysis and peritoneal dialysis achieve comparable potassium reduction in severe hyperkalemia, so if urgent-start dialysis is needed, modality choice can be individualized 5.